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INTRODUCTION
Hypoxia can be defined as a condition in which the body, or a part of it, is deprived of adequate
oxygen supply. 
Human beings can experience hypoxia as a result of insufficient ventilation (such as during apnoea,
acute  or  chronic  respiratory  failure,  breathing  low-oxygen  content  air  –  for  example  at high
altitude), insufficient oxygen-binding/oxygen-carrying capacity of blood (such as during anaemia
and carbon monoxide or  cyanuric acid poisoning), or insufficient blood flow to peripheral tissues
(such as in heart failure, shock, and arterial occlusion).
In physiological conditions, hypoxia is experienced by ascending at high altitudes. At sea level, air
pressure (Patm) is 760 mmHg with a fixed percentage distribution of gases  [oxygen (O2) 20.93%,
carbon dioxide (CO2) 0.03%, and  Nitrogen (N2) 79.04%]. At higher altitudes, air pressure decreases
and reaches 380 mmHg at 5840 mt and 250 mmHg on the summit of Mount Everest (8878mt), but
the percentage distribution of gases does not change. According to Dalton's Law, this fact implies a
reduction in the partial pressure of O2 from 159 mmHg at sea level (i.e. 20.93% of 760 mmHg), to
79 mmHg at 5840 m (i.e. 20.93% of 380 mmHg), and 52 mmHg at the top of Mount Everest (i.e.
20.93% of 250 mmHg). Moreover, as we breathe the inspired air is moistened by the upper airways
with water vapor at a pressure (PH2O) of 47 mmHg that doesn't change at high altitudes.
Considering that the partial pressure of CO2 inside the alveoli (PalvCO2) is around 40 mmHg and that
in physiologic conditions it depends on ventilation and CO2 production  regardless of the altitude,
the  partial  pressure  of  O2 at  the  alveolar  level  (PalvO2)  can  be indirectly  calculated  from  the
following alveolar gas equation:
                                          P alvO 2=FiO2 x (P atm−PH 2o )−P alv CO2/RQ
where FiO2 is the fraction of O2 in inspired air and RQ is the Respiratory Quotient (Cruickshank et
al. 2004; Sharma et al. 2019). 
According to this equation,  PalvO2  is equal to 99 mmHg at sea level. Considering that the  partial
pressure of O2  in pulmonary capillaries is equal to 40 mmHg, there is a 60 mmHg gradient that
produces a shift of  O2  from the alveoli to the capillary bed, thereby allowing blood oxygenation.
Starting from these considerations, it's easy to calculate PalvO2 at 5840 mt and at the top of Mount
Everest, which is 19.69 mmHg and -7.51 mmHg respectively. These levels of hypoxia are expected
to impair the oxygen exchange between blood and alveolar air and rapidly lead to death.
Fortunately, when the human body undergoes acute or chronic hypoxia, it responds with a series of
adjustments and adaptations  both at the cellular and systemic levels.  These mechanisms allowed
Reinold  Meissner  to  reach  the  peak  of  Mount  Everest  (8878  mt)  in  1978  without  oxygen
supplementation.
Cellular response to hypoxia.
Hypoxia  is  a  very  challenging  condition  for  cellular  metabolism  because  it  impairs  oxidative
phosphorilation,  the  main  metabolic  pathway  that  synthesizes  adenosine  triphosphate  (ATP)
utilizing  O2. A low ATP concentration leads to a reduced Na+/K+ ATPase activity, impeding the
homeostatic control of cellular membrane potential. Partial depolarization opens voltage-gated Ca2+
channels, increasing the net influx of this ion that activates the apoptotic enzymatic cascade leading
to cellular death (Michiels 2004).
Cells respond to this condition in different ways. One important mechanism is the inhibition of the
most ATP consuming activities, like RNA/DNA and protein synthesis, prioritizing Na+/K+ ATPase
activity  and  Ca2+  homeostasis  (Buttergeit  et  al.  1995).  Another  fundamental  adaptation  is  the
enhancement of anaerobic glycolysis by Phosphofructokinase-1 (PFK-1) activation, a key enzyme
of this energetic pathway. PFK-1 is allosterically activated by adenosine monophosphate (AMP),
adenosine diphosphate (ADP), and fructose 2,6 biphosphate. In particular, fructose 2,6 biphosphate
is  synthesized  by  Phosphofructokinase-2  (PFK-2)  which  is  mainly  regulated  by  AMP  kinase
(AMPK) through phosphorylation (Hue et al. 1987; Marsin et al. 2000). AMPK can be considered
the most important cellular energy sensor because it can activate catabolic pathways that produce
ATP and inhibit anabolic ATP-consuming pathways (Hardie and Hawley 2001; Hardie 2001; Kemp
et al. 1999). These effects are achieved by phosphorylation of enzymes directly involved in these
metabolic reactions or regulating gene expression through phosphorylation of transcription factors.
For  example,  AMPK  can  increase  the  translocation  of  Glut-4  (  the  insulin-mediated  glucose
transporter) to the cellular membrane, increasing glucose inflow into the cell. Moreover, it inhibits
fatty  acid,  triglycerides  and sterol  synthesis  and reduces  the  expression  of  genes  that  code  for
enzymes  of gluconeogenesis  and fatty acid synthesis  (Hardie and Hawley 2001).  These actions
make AMPK a key regulator of cell metabolism in low energy conditions like hypoxia.
Another fundamental actor in cellular homeostasis under hypoxia is the Hypoxia Inducible Factor 1
(HIF-1), a transcription factor that promotes the expression of genes involved in oxygen delivery
and anaerobic metabolism,  exerting its  effect  on cellular  as well  as on systemic  level  (Lundby
2013). HIF-1 is a heterodimer formed by two different proteins, HIF-1α and HIF-1β, which are
constitutively expressed in human cells. Instead of being in a stable form as HIF-1β, HIF-1α has a
brief half-life of 5-8 minutes in normoxic conditions, thanks to continuous hydroxylation by two
different  enzymes,  PHD  and  FIH-1  which  use  oxygen  as  the  substrate  of  their  activity.
Hydroxylated HIF-1α is degraded by the ubiquitin-proteasome system and prevented from binding
with  HIF-1β.
In hypoxia, PHD and FIH-1 lower their hydroxylation activity and HIF-1α can dimerize with  HIF-
1β,  enters  the  cellular  nucleus  and  works  as  a  transcription  factor,  interacting  with  the
transcriptional  co-activators  P300  and  CBP.  This  heterodimer  can  bind  to  Hypoxia  Response
Elements (HRE) at target gene loci thereby promoting the expression of numerous genes involved
in the cellular and systemic response to hypoxia (Koyasu et al 2018, Sousa et al 2019).
HIF can increase the expression of enzymes involved in the anaerobic glycolytic pathway [such as
phosphoglycerate kinase,(PKG) and lactate dehydrogenase A (LDHA)], in glucose transport from
plasma  to  intracellular  space  (such  as  GLUT1),  in  neoangiogenesis  [(such  as  the  Vascular
Endothelial Growth Factor (VEGF)] (Hu et al. 2007), and in new erythrocytes production, [such as
erythropoietin (EPO)]. (Lundby 2013)
The level of  HIF-1α starts to rise rapidly and peaks after a few hours of hypoxia, progressively
declining towards basal levels in the next hours-days (Lundby 2009). This  behavior is probably
related to acclimatization that stops the hypoxic stimulus at the cellular level, decreasing  HIF-1α
stabilization (Lundby 2009).
Local Vascular tone regulation and hypoxia.
The delivery of oxygen to peripheral tissues depends on blood flow and blood oxygen content. As
blood oxygen content lowers during hypoxia,  the peripheral arteries vasodilate to increase local
blood flow. In contrast, pulmonary arteries vasoconstrict in response to hypoxia, representing the
only exception to this mechanism as we'll explain later. 
Hypoxia can produce vasodilation thanks to direct and indirect-paracrine mechanisms. The main
direct effects are potassium ATP-sensitive membrane channels (K-ATP) opening and endothelial
Nitric Oxide Synthase (eNOS) activation.  K-ATP is highly represented on smooth muscle cells
membrane and opens in response to low ATP intracellular concentrations, as happens in hypoxic
conditions. The increase of K+ outflow hyperpolarizes the cell membrane, closing the Ca2+ voltage-
gated membrane channels, preventing Ca2+ from entering into the intracellular space and ultimately
reducing smooth muscle contraction (Dart et al. 1995). eNOS synthesizes Nitric Oxide (NO) from
oxygen and L-arginine and gives L-citrulline as a byproduct. NO diffuses to near vascular smooth
muscle  cells  and increases intracellular  production of cyclic  guanosine monophosphate  (cGMP)
(Pearce at al. 1990) and this in turn activates several protein kinases involved in Ca2+  homeostasis
and K+ conductance, thereby inhibiting smooth muscle contraction (Surks et al. 1999;   Bolotina et
al.  1994).  The indirect-paracrine  mechanism is  mediated by erythrocytes  and involves different
paracrine  molecules  like  NO,  prostaglandins  (in  particular  PGI2 and  PGE2),  adenosine  and
Epoxyeicosatrienoic acids (EET). (Hoiland et al. 2016). In fact, erythrocytes can generate NO from
circulating  nitrites  (NO2-)  and deoxyhemoglobin,  which  acts  as  nitrite  reductase  in  low-oxygen
conditions (Kim-Shapiro et al. 2006). Moreover, hemoglobin can bind to S-Nitrosothiol (SNO) in
the lungs and form a complex called S-nitrosohemoglobin, which can work as a NO donor in the
peripheral tissues inducing vasodilation (Jia et al. 1996). Another important erythrocyte-mediated
mechanism  is  ATP  release  induced  by  hypoxia  (Bergfeld  et  al.  1992;  Ellsworth  et  al.  1995;
Ellsworth  et  al.  2009).  ATP  binds  to  endothelial  P2Y2 purinoreceptor  and  starts  a  series  of
intracellular signal cascades that culminate in the liberation of NO, adenosine, prostaglandins, and
EET (Hoiland et  al  2016). Adenosine, Prostaglandins and EET bind to specific  endothelial  and
smooth muscle cells receptors resulting in reduced Ca2+ sensitivity, reduced Ca2+ influx, increased
K+ outflow and increased local production of NO. The role of these molecules in hypoxia-mediated
vascular tone regulation is well documented in animal models, but further studies are required to
confirm the same action in humans (Hoiland et al. 2016).
All these mechanisms had been advocated to be responsible for hypoxia-induced vasodilation in
different organs like the brain (Hoiland et al. 2016, Pearce et al 1990), the skeletal muscle (Dinenno
et al. 2016), and the coronary circulation (Tune 2007). Regarding coronary circulation, since O2
extraction is very high in normal resting conditions, the only mechanism available to increase O2
delivery in acute hypoxia is vasodilation, which has been shown to occur in healthy individuals
exposed to acute normobaric hypoxia simulating an altitude of 4500 mt both in resting conditions as
well as after exercise (Wyss et al. 2003). 
In contrast, pulmonary arteries respond to hypoxia with vasoconstriction. This mechanism is very
important in ventilation/perfusion (V/Q) matching because it shifts blood from poorly ventilated
and  hypoxic  alveoli  (for  example  it  happens during atelectasis)  towards  better-ventilated  lung
districts.  Unfortunately,  this local response to hypoxia involves the lungs globally when a low-
oxygen content gas mixture is breathed, as happens at high altitudes, increasing pulmonary arterial
pressure. 
The  peculiar  pulmonary  arteries  response  is  likely  due  to  vascular  smooth  muscle  cells
depolarization, which activates  Ca2+ voltage-gated membrane channels and increases  Ca2+ inflow
(Michiels) This depolarization is connected to the inactivation of specific K+  channels like Kv1.5,
Kv2.1 and Kv9.3 (Archer et al. 1998; Hulme et al. 1999). Another source of intracellular Ca2+ is the
sarcoplasmic reticulum that seems to release Ca2+  into the cytosol in hypoxic conditions (Swenson
2013). 
All these changes are probably initiated by the impairment of redox state into the smooth muscle
cells  and  the  increase  of  reactive  oxygen  species  (ROS)  production  that  activates  different
intracellular signaling pathways involved in Ca2+  homeostasis and sensitivity (Schumacker 2011).
Moreover,  it  seems  that  near  endothelial  cells  may  be  a  source  of  ROS  and  could  release
Endothelin-1 in response to hypoxia.  Endothelin-1 binds to Endothelin A receptors and induces
vascular  smooth  cell  contraction  (Aaronson  et  al.  2002).  Finally,  Wang  et  al.  illustrated  an
alternative  mechanism  that  can  contribute  to  pulmonary  vasoconstriction.  They  proposed  that
capillary vascular  endothelial  cells  that  reside in proximity to  alveoli  depolarize  in  response to
hypoxia  and  propagate  the  signal  via  inter-endothelial  connexion  40-dependent  gap  junctions,
working as an “oxygen sensor” that communicate  to proximal  arteries the oxygenation state of
alveolar space inducing vasoconstriction (Wang et al. 2012).
Blood response to hypoxia.
Arterial oxygen content per 100 ml  (CaO2) defines the total oxygen-carrying capacity of the blood.
Its value can be calculated from the following equation: 
                                                                      
Ca O2=(1 ,34×SpO2×Hb )+(0 , 0031×PaO 2)  
where  SpO2  is the oxygen saturation of hemoglobin, Hb is the hemoglobin concentration in blood
and PaO2  is the partial pressure of oxygen in arterial blood.
It follows that an increase in Hb brings to an increase in CaO2 and oxygen-carrying capacity of the
blood. 
One of the most important effects of the HIF complex as a hypoxia-sensible transcription factor is
the  increase  of  Erythropoietin  (EPO)  expression  at  the  kidney  level.  EPO  is  the  hormone
responsible for new red blood cell production, which is the key factor in increasing hematocrit and
hemoglobin  in  response  to  hypoxia  (Ploszczyca  et  al.  2018).  EPO  production  increases  after
minutes to hours following acute hypoxia exposure (Eckardt et al. 1989) and reaches a peak after 1-
3 days (Berglund et al. 1992) if hypoxia persists. Even if the hypoxic stimulus continues in the
subsequent  days,  EPO level  starts  to  decline  and  it  reaches  a  plateau  slightly  above  sea-level
concentrations; this behavior mimics  HIF-1α time course, being likely both the expression of good
acclimatization (Ploszczyca et al. 2018). EPO takes few weeks to exert its effects, but hematocrit
can rise after a few hours of hypoxia exposure. This phenomenon is linked to a shift of plasma and
extracellular fluids to intracellular space, with a decrease in plasma volume that can reach 20% of
total volume (Hannon et al. 1969). The mechanisms responsible for this response are still unclear,
but it seems that they depend on various volume-regulating hormones like the renin-angiotensin
system and atrial  natriuretic  peptide  (ANP),  which has  been shown to be increased after  acute
hypoxia (Albert et al. 1989).
Another fundamental response to hypoxia is the change of hemoglobin P50  , the partial pressure of
oxygen at which oxygen saturation is 50%. P50  can be considered a measure of hemoglobin affinity
for oxygen: a low  P50  indicates a high-affinity state that facilitates hemoglobin oxygen loading in
pulmonary capillaries but impairs unloading at tissue level; a high  P50  indicates the opposite. P50 is
influenced  by several  factors  like  blood  pH,  carbon  dioxide  tension,  the  concentration  of  2,3-
diphosphoglyceric  acid,  magnesium,  ATP,  chloride,  blood  temperature  and  the  amount  of
hemoglobin  bound  to  carbon  monoxide.  It  was  demonstrated  that  hypoxia  increases  the  blood
content  of   2,3-diphosphoglyceric  acid,  magnesium,  ATP  and  chloride  (Peronnet  et  al.  1991;
Friedmann et al. 2005) inducing an increase in P50 of 0,3- 0,7 mmHg (Lundby et al 2004; Wagner t
al. 2002). Thus, it seems that a low-affinity state is advantageous in hypoxic conditions at the cost
of a lower ability of hemoglobin to bind oxygen in lung capillaries (Lundby 2013). 
Ventilation and hypoxia.
According to the alveolar gas equation, PalvO2 depends on the amount of O2 in inspired air and the
PalvCO2. As we ascend to high altitudes, the partial pressure of inspired O2 decreases while PalvCO2
doesn't change, so pulmonary ventilation (Ve) has to increase in order to increment the amount of
O2 arriving at the alveolar space and to eliminate CO2.
At rest, acute exposure to hypoxia induces an initial increase (seconds to minutes) in both Tidal
volume (TV) and respiratory frequency (RF). After 10 minutes,  both variables decline until  30
minutes after initial exposure, when Ve stabilizes above normoxic levels. If the hypoxic stimulus
persists, Ve gradually increases in the subsequent hours/days until it  reaches a plateau (Lundbty
2013). 
These  adaptations  allow PalvO2 and  blood  oxygen  saturation  (SpO2)  to  increase  and  PalvCO2  to
decrease within about 14 days before the effects of EPO become evident at the cost of respiratory
alkalosis that is in turn compensated by the action of kidneys (Lundby 2013). The increase in Ve in
chronic  adaptation  to  hypoxia  seems  to  be  related  to  an  increase  in  carotid  chemoreceptors
sensitivity to O2. In support of this concept, it has been shown that after one day of hypoxia, gene
expression increases in carotid body cells enhancing cell number (Wang et al. 2008). Moreover, in a
goat model Bisgard et al. isolated the carotid bodies from systemic circulation and perfused them
with  hypoxic  blood obtaining  an  increase  in  Ve,  thus  demonstrating  the  importance  of  carotid
chemoreceptors in hypoxic-mediated hyperventilation (Bisgard et al. 1986).
Another source of blood oxygenation impairment in hypoxic conditions is the ventilation/perfusion
(V/Q) mismatch. In normoxic conditions, as PalvO2 decreases in poorly ventilated alveoli, proximal
pulmonary  arterioles  vasoconstrict  shifting  blood  to  better-oxygenated  alveoli.  In  hypoxic
conditions  PalvO2 globally drops,  thus inducing diffuse vasoconstriction  which impairs  V/Q and
reduces blood oxygenation (Wagner et al. 1987;see “Local vascular tone regulation and hypoxia”
chapter). This effect is greatly amplified by the increased cardiac output that occurs in hypoxia
which accelerates blood flow in lung vessels thus reducing the time available for gas exchange
between capillaries and alveolar space (Lundby 2013).
Furthermore,  it  is  worth  mentioning  the  interstitial  pulmonary  edema  caused  by  an  excessive
hypoxic pulmonary vasoconstriction (HPV) that impairs oxygen diffusion at the alveolar-capillary
interface amplifying deoxygenation, a situation that could precipitate in life-threatening pulmonary
edema (Luks et al. 2017). 
Central Hemodynamic changes in hypoxia.
Since oxygen blood content  decreases in hypoxic conditions,  regulation of cardiac output  (CO)
becomes fundamental to guarantee a sufficient oxygen delivery to peripheral tissues. As expected,
at rest after acute exposure to hypoxia CO increases. This adjustment is related to an increase in
heart rate (HR), while stroke volume (SV) has been reported to be unchanged (Talbot et al. 2005) or
decreased (Stembridge et al 2015).
Blood pressure (BP) remains unchanged or slightly increases after acute hypoxia exposure (Naeije
2010) whereas systemic vascular resistance (SVR) decreases. The effect on SVR is the result of the
balance between the hypoxia-mediated local vasodilation (see “Local Vascular tone regulation and
Hypoxia”  chapter)  and  the  vasoconstriction  due  to  the  sympathetic  nervous  system  (SNA)
activation, with the former prevailing on the latter.
If hypoxic stimulus persists for different days/weeks, CO returns to normoxic levels, HR remains
higher and SV lower with respect to normoxia (Klausen 1966; Vogel et al 1967). Considering that
left ventricular (LV) contractility seems to be preserved or enhanced in chronic hypoxia (Reeves et
al. 1987; Suarez et al 1987), SV reduction has been considered to be related to plasma volume
contraction (see “Blood response to Hypoxia” chapter), increased right ventricle (RV) afterload due
to pulmonary arteries vasoconstriction, and impaired diastolic function (Stembridge et al. 2015a).
Plasma volume restoration by isotonic Dextran infusion has been reported to improve SV in some
investigations  (Siebenmann  et  al.  2013),  while  other  research  did  not  report  any improvement
(Calbet et al. 2004).
Recently, echocardiographic studies (Stembridge et al. 2014; Stembridge et al. 2015b) contributed
to shed light on the SV reduction after 10 days of exposure to high altitude (5050 mt). The authors
reported  a  decreased  left  ventricular  end-diastolic  volume  (LV EDV),  an  increased  pulmonary
systolic  pressure  (PSP),  an  enhanced  LV  systolic  function  [assessed  as  ejection  fraction  (EF)
obtained  with  echocardiography,  and  as  strain,  rotation,  and  twist  obtained  by  tissue  Doppler
imaging], a decreased RV systolic function [assessed by tricuspid annular plane systolic excursion
(TAPSE)  and  RV  longitudinal  strain],  a  preserved  LV  diastolic  function  (assessed  by  left
ventricular untwist velocity and apical diastolic rotational velocity analysis) with a decreased mitral
inflow  E/A  ratio  (a  load-dependent  index  of  diastolic  function)  probably  related  to  LV  EDV
reduction.  These  results  seem to indicate  that  the main  responsible  for  the SV reduction  is  an
afterload dependent depression in RV function that reduces LV filling.
Maximal HR in hypoxia has been reported to be reduced (Lundby et al. 2001).  This effect is related
to an increased parasympathetic drive since maximal heart rate is restored after administration of
glycopyrrolate, a parasympathetic blocking agent. The increased HR is accompanied by a decrease
in maximal SV, so that CO is unchanged in this experimental setup. (Boushel et al. 2001). This
result  suggests that  the regulated  variable  at  maximal  effort  is  CO which is  likely adjusted by
reducing SV in order  to allow an appropriate  transit  time of  red blood cells  in  the pulmonary
circulation and more efficient blood oxygenation (Boushel et al. 2001). 
Autonomic regulation of the cardiovascular system in hypoxia. 
The Autonomic  Nervous  System plays  a  pivotal  role  in  systemic  cardiovascular  adjustment  to
hypoxia.  The  increase  in  HR  that  occurs  in  acute  hypoxic  conditions  depends  on  both
sympathoexcitation  and  vagal  withdrawal.  Indeed,  it  has  been  demonstrated  that  muscle
sympathetic  nerve  activity  (mSNA),  a  marker  of  sympathetic  nervous  system  activation,  is
increased after hypoxia exposure (Saito et al. 1988). The vagal contribution to HR in hypoxia has
been studied only indirectly by using HR variability (HRV) analysis, which seems to indicate a
reduced vagal tone at rest after acute hypoxia exposure (Perini et al. 1996; Princi et al. 2008).
Pharmacological  blockade has  been used to assess  the relative  contribution  of sympathetic  and
parasympathetic  branches  of  the  autonomic  nervous  system  to  HR  under  acute  hypoxia.  The
isolated inhibition of sympathetic (using propanolol) or parasympathetic (using atropine) nervous
system do not affect the tachycardic effect of hypoxia, while simultaneous inhibition abolishes it
(Koller et al. 1988). This indicates that both branches are involved in HR response during acute
exposure to hypoxia. 
There are many putative contributors to these changes in the autonomic nervous system activity.
Carotid  and  aortic  chemoreceptors  are  the  main  peripheral  sensors  of  hypoxia.  Carotid
chemoreceptors are primarily sensitive to PaO2 , while aortic chemoreceptors are responsive to  CaO2
(Lahiri  et  al.  1981).  It  seems  that  carotid  chemoreceptors  are  the  main  responsible  of
hyperventilation  and vasoconstriction  response  to  hypoxia,  while  aortic  chemoreceptors  are  the
main determinant of hypoxia-mediated tachycardia (Niewinski et al. 2014). However, other studies
indicate  that carotid  chemoreceptors  activation exerts  an important  indirect  effect  on HR, since
hyperventilation triggers the pulmonary stretch receptors and reduces the vagal traffic to the heart
(Kato  et  al.  1988).  Moreover,  carotid  chemoreceptors  increase  the  level  of  circulating
catecholamines, further influencing HR when activated (Siebenmann et al. 2015).
Furthermore, acute hypoxia induces a shift of the baroreflex set-point to a higher pressure level,
thus causing an increase in sympathetic tone and a vagal withdrawal (Halliwill et al. 2003; Querido
et al. 2011). The precise mechanism of this phenomenon remains unclear, but it seems related to
peripheral chemoreceptors activation (Halliwill et al. 2003). Besides, hypoxia triggers baroreflex
thanks to its vasodilator effect on peripheral arteries, and this further increases the sympathetic tone
and inhibits the parasympathetic activity (Calbet et al. 2014).
If the hypoxia stimulus persists for days/weeks, CaO2  is partially restored by EPO-related increase
in hematocrit and red blood cells, and this effect is further amplified by plasma volume contraction.
Nonetheless,  PaO2   only  slightly  increases  during  chronic  hypoxia.  It  derives  that  aortic
chemoreceptors should be less active than carotid chemoreceptors in chronic hypoxic conditions,
with a consequent reduction in tachycardia and a preserved hyperventilation and vasoconstriction.
On the contrary, tachycardia persists after chronic hypoxia exposure (Siebenmann et al. 2015). This
effect  is  likely  related  to  a  higher  sensitivity  of  carotid  chemoreceptor  to  reduced  PaO2  which
triggers sympathetic activation (Mazzeo et al. 1995; Hansen et al. 2003). Moreover, the baroreflex
set-point is shifted to higher pressure and this enhances sympathetic traffic to the heart even in the
presence of reduced aortic chemoreceptors activation (Siebenmann et al. 2015). 
The  effects  of  chronic  hypoxia  on  the  parasympathetic  system are  less  clear.  Pharmacological
blockade of muscarinic receptors increases HR more after altitude acclimatization than at sea level
(Wolfel et al. 1998; Bao et al. 2002), but HRV analysis shows a persistent vagal withdrawal after 18
months at high altitude (Dhar et al. 2014). A possible explanation for these conflicting results is the
augmentation  of  muscarinic  receptor  density  after  chronic  hypoxia  exposure,  which  has  been
demonstrated in rats (Kacimi et al. 1993). 
Exercise in hypoxia.
In light of all the described effects of hypoxia on the human body, it's easy to imagine how exercise
in hypoxia is challenging. Oxygen uptake (VO2  ) is the amount of oxygen consumed by the body in
one minute. VO2  is directly related to workload and it increases linearly as exercise load increases.
According to Fick's equation, VO2  can be expressed as the product of CO and the difference in  O2
content between arterial and venous blood (CaO2 – CvO2) :
                                                            VO2=CO x (C a O2−C v O2)
As a subject undergoes hypoxia, CaO2 diminishes while CO increases to compensate for it. A well-
known measure of aerobic exercise performance is maximal oxygen uptake (VO2 max), which is the
rate of oxygen uptake achieved at the end of a maximal incremental exercise test when VO2  reaches
a plateau and any load increment  does not lead to any further VO2  rise. Since during a maximal
incremental exercise test it's difficult to reach the true VO2 max, peak oxygen uptake (VO2 peak) at the
end of the test is often used as a surrogate measure. Being VO2 max/peak directly related to the weight
of the subject, these measures are often expressed in ml*min -1*kg-1 in order to allow comparison
among individuals with different body sizes.  
As expected, hypoxia induces a reduction in VO2 max  which depends on the altitude or the partial
pressure of inspired O2. It has been demonstrated that above 1500 mt of altitude, VO2 peak is reduced
by 1% for  every  100mt  of  altitude  (Fulco  et  al.  1998).  At  the  summit  of  Mount  Everest,  the
reduction reaches  80%, thus leaving very little  exercise capacity  left.  This VO2max   reduction is
amplified in elite athletes. Indeed, it has been shown that in these subjects VO2max  starts to decline at
580 mt of altitude (Gore et al. 1996) and the reduction is higher compared to untrained individuals
at the same altitude (Fulco et al. 1998). These evidences are likely related to the enhanced muscle
extraction of O2 in athletes during exercise, which is preserved even when PaO2  drops in hypoxic
conditions,  resulting  in  a  greater  oxygen  desaturation  and  exercise  capacity  impairment  (Van
Thienen et al. 2016).
Acclimatization  increases  CaO2 by  increasing  the  amount  of  circulating  red  blood  cells  and
hematocrit,  a potentially positive effect on VO2max   according to Fick's equation. Actually,  it has
been demonstrated that after 1-2 months of EPO treatment VO2max  improves up to 3500 mt, without
affording any additional positive effect above this altitude (Robach et al. 2008).
Submaximal exercise in hypoxia showed a level of impairment which is comparable to the maximal
one. The energetic cost of an exercise bout at constant power is similar between sea level and high
altitude,  but the relative exercise intensity (expressed as a percentage of VO2max) is increased as
VO2max declines with hypoxia exposure (Lundby 2013). Nonetheless, it has been shown that the time
to exhaustion for submaximal exercise at a constant load performed at 4300 mt of altitude improves
after  16  days  of  acclimatization,  thereby  suggesting  that  acclimatization  can  be  beneficial  for
submaximal exercise performance at higher altitudes too (Horstman et al. 1980).
Differently from aerobic performance, anaerobic exercise seems not to be affected at high altitude.
Indeed, activities that depend on air friction (like 100mt running or throwing sports) are advantaged
because of the reduced air density. Nonetheless, hypoxia greatly impairs the regeneration of ATP
and glycogen after aerobic exercise requiring longer resting time to fully recover after an exercise
bout (Lundby 2013).
Considering the effects of hypoxia and the consequent potential benefit on aerobic exercise, several
investigators  tried  to  asses  whether  training  at  high  altitudes  improved  athletes'  performance.
Different training regimens have been tested (live low/train high, live high/train high, live high/train
low), but the only one that  seems to give a beneficial  effect is the live high/train low (LHTL)
protocol. LHTL consists in leaving and sleeping at moderate altitudes (3000 mt) and training at
lower altitudes or sea-level.  This regimen seems to be beneficial  because it evokes the positive
effect of hypoxia and at the same time it allows the athlete to train at intensities that couldn't be
maintained under oxygen deprivation (Levine et al. 1997).
Metaboreflex and hypoxia.
An  important  mechanism  for  cardiovascular  adaptation  to  exercise  is  the  so-called  "muscle
metaboreflex".  When the  muscles  are  activated  during exercise  they produce several  metabolic
byproducts such as lactate, adenosine, potassium, and phosphate. These substances are sensed by
type IV nerve endings in the muscles which in turn convey the information to the cardiovascular
control centers located in the caudal and rostral ventrolateral medulla. This information is about the
degree of metabolic activation and the presence of any mismatch between the local circulation and
the  contracting  muscle  thereby  evoking  a  cardiovascular  reflex,  i.e.  the  metaboreflex.  This
mechanism is mediated by the sympathetic autonomic nervous system and consists in an increase in
SVR and  an  increase  in  SV,  the  latter  being  related  to  enhanced  cardiac  contractility  and  an
increased  cardiac  pre-load  deriving  from  a  venoconstriction  that  recruits  the  Frank-Starling
mechanism (Nobrega et al. 2014). The vasoconstrict effect of the metaboreflex-induced increase in
sympathetic  activity  is  counteracted  in  active  muscles  by  the  vasodilatory  effect  of  molecules
produced during exercise, like nitric oxide, adenosine, and prostacyclin. This phenomenon is called
"functional  sympatholysis"  and allows a  shift  of blood flow from inactive tissues to  exercising
muscles  in  order  to  match  their  metabolic  demand  (Tschakovsky  et  al.  2002).  All  these
modifications produce an increase in BP that is directly related to exercise intensity and that allows
optimal muscle perfusion without impairing blood delivery to other noble tissues such as the brain
and the heart (Crisafulli et al. 2015).
Metaboreflex  acts  during  exercise  in  concert  with  other  two important  reflex  mechanisms,  the
"central  command"  and  the  "mechanoreflex".  The  central  command  consists  in  the  direct
cardiovascular response to the activation of the motor area of the cerebral cortex during exercise.
This phenomenon is possible thanks to a direct neural connection of these cortex areas to the brain
stem and its nuclei involved in cardiovascular regulation. The central command triggers an initial
hemodynamic adjustment to exercise that is then finely tuned by the activation of the metaboreflex
and the mechanoreflex (Crisafulli et al. 2015).
The mechanoreflex behaves similarly to the metaboreflex,  but it conveys information about the
mechanical status of the contracting muscle. Mechanoreflex works thanks to type III nerve endings
within the muscles and tendons that inform the cardiovascular control areas about the stretching and
tension that develops in active muscles (Hollander et al. 1975; Fischer et al. 2004). Investigators
often refer to mechanoreflex and metaboreflex together as the forming parts of the "exercise pressor
reflex". 
These  3  mechanisms  interact  and  influence  each  other  during  exercise  and  some  level  of
redundancy exists. All of them exert a similar effect on the cardiovascular system by modulating the
autonomic  nervous  system but  with  some differences.  Indeed,  while  the  central  command  and
mechanoreflex  seem  to  induce  an  increase  in  sympathetic  drive  and  a  vagal  withdrawal,
metaboreflex exerts its effect only on the sympathetic branch (Crisafulli et al. 2015).
Moreover, they exert direct effects on baroreflex as they produce a shift in the baroreflex operating-
point to higher values while preserving baroreflex sensitivity (Iellamo et al. 1997; Iellamo et al.
2001;  Potts  et  al.  1993;  Ogoh  et  al.  1993).  These  modifications  are  important  to  buffer  any
sympathetic overdrive and to avoid any excessive peripheral vasoconstriction (Raven et al. 2006;
Joyner 2006).
An experimental method often used to isolate metaboreflex from both mechanoreflex and central
command is the post-exercise muscle ischemia (PEMI), which consists in the occlusion of blood
flow on a limb that has just ceased to exercise. This maneuver impedes the washout of metabolites
produced during exercise and amplifies the activation of the metaboreflex, avoiding the influence of
the motor  areas of the cortex and mechanoreflex  on the cardiovascular  control  areas  while  the
metaboreflex is active (Crisafulli et al. 2003; Crisafulli et al. 2008). PEMI has been extensively
used to evaluate  the cardiovascular  response to metaboreflex activation.  Despite  the changes in
hemodynamic parameters evoked by this method, PEMI showed no effect on HR (Piepoli et al.
1995; Iellamo et al. 1999). This result is likely related to the increased parasympathetic influence on
the  heart  evoked  by  the  baroreflex  activation  that  counterbalances  the  metaboreflex-mediated
sympathetic drive that occurs during this maneuver (Crisafulli et al. 2015). 
Some  investigators  tried  to  shed  light  on  the  effects  of  acute  hypoxia  on  the  metaboreflex.
Houssiere and colleagues (Houssiere et al. 2005) evaluated the effect of 3 minutes of hypoxia alone,
3 minutes of isometric handgrip exercise alone, and 3 minutes of both intervention combined on
mean BP, HR, mSNA, and Ve. The same variables were also evaluated for 3 minutes after these
interventions applying a forearm circulation arrest  maneuver,  a protocol similar to PEMI. Their
results showed that hypoxia alone increased mSNA, HR, Ve, with no change in mean BP while
exercise  alone  increased  all  the  measured  variables.  The  combination  of  hypoxia  and  exercise
increased all  the variables  studied,  with an enhanced Ve and HR response.  During the forearm
circulation arrest, all variables returned to baseline level in 3 minutes after hypoxia alone, while Ve
and mSNA remained elevated after exercise alone and exercise in hypoxia, and mean BP stayed
elevated only after exercise in hypoxia.
Gujic  et  al.  (Gujic  et  al.  2007)  performed  a  similar  experimental  protocol  that  consisted  in  4
interventions: normoxic rest (used as control), normoxic isometric handgrip exercise, hypoxia alone
and hypoxic isometric handgrip exercise for 3 minutes, each one followed by 3 minutes of forearm
circulation arrest. Furthermore, they assessed the baroreflex control of sympathetic outflow and R-R
intervals  inducing variations  on BP pharmacologically.  The  studied variables were systolic  BP,
diastolic  BP,  HR,  Ve, and mSNA. Furthermore,  %mSNA/mmHg was  studied  as  a  measure  of
baroreflex  sensitivity  of  sympathetic  outflow,  while  ms/mmHg was  evaluated  as  a  measure  of
baroreflex sensitivity of R-R intervals. Finally, the operating point of baroreflex regarding systolic
BP,  diastolic BP, mSNA  and R-R intervals were evaluated to complete the baroreflex analysis.
Their results demonstrated that when chemoreflex and metaboreflex are activated simultaneously,
as it happened when the forearm circulation arrest was applied after exercise in hypoxia, all the
examined variables remained elevated after 3 minutes, with a complementary effect on systolic BP
(that was elevated after exercise alone and not after hypoxia alone) and on HR (that was elevated
after hypoxia alone and not after exercise alone), with no significant differences in Ve and mSNA,
that were similarly influenced after hypoxia alone and normoxic exercise.
Regarding  baroreflex  control  of  sympathetic  outflow,  the  investigators  reported  that  baroreflex
sensitivity  (expressed as  %mSNA/mmHg)  was increased  during forearm circulation  arrest  after
hypoxia alone without any modification in the operating point of diastolic BP and mSNA, while it
was unchanged after normoxic and hypoxic exercise with an increased operating point of diastolic
BP  and  mSNA.  Moreover,  results  from baroreflex  control  of  R-R  interval  analysis  showed  a
decreased cardiac baroreflex sensitivity (expressed as ms/mmHg) during forearm circulation arrest
after hypoxia alone and hypoxic exercise, while it remained unchanged after normoxic exercise.
These results were correlated to a reduced end-tidal pressure of CO2 that occurs during hypoxia
exposure as a consequence of an increased Ve, so they can not be considered directly related to the
hypoxic stimulus. Concerning the operating point of systolic BP and R-R interval, the former was
shifted to higher values after normoxic and hypoxic exercise while the latter was shifted to lowers
values after hypoxia alone and hypoxic exercise.
From these results, the investigators concluded that metaboreflex and hypoxia-induced chemoreflex
evoke  partially  overlapped  responses  on  the  cardiovascular  system  and  ventilation, without
summation when activated simultaneously. Furthermore, they exert a different effect on baroreflex
control of sympathetic outflow and R-R intervals, with the metaboreflex being more active on the
operating point of BP and mSNA and the chemoreflex having a greater effect on the operating point
of R-R intervals. It is worth to mention that regarding baroreflex sensitivity on the sympathetic
outflow, metaboreflex seems to prevail on chemoreflex since the augmentation of %mSNA/mmHg
induced by chemoreflex was abolished by the concomitant activation of metaboreflex. The authors
suggested that these results were likely related to a partial overlap of chemoreflex and metaboreflex
central  projection  in  the  brain  stem  (in  particular  in  the  nucleus  of  tractus  solitarii  and  the
paramedian reticular nuclei), where different interactions between the two stimuli could take place.
Unfortunately, these studies did not include hemodynamic parameters like SV and SVR making the
cardiovascular system analysis still incomplete.
AIM OF THE RESEARCH
Unlike the extensive bibliography published on the effects of hypoxia at the cellular level that was
worth the 2019 Nobel Prize in Medicine, the effects at the systemic level are partly unclear and
require  new studies  to  better  elucidate  the  mechanisms  behind  them.  My work  was  aimed  at
following  this  strand  of  research.
In particular, the main focus of my study was to better elucidate the interaction between hypoxia
and metaboreflex activation, focusing on hemodynamic parameters (such as SV and SVR) that have
never  been  studied  in  the  past.  To  reach  this  goal,  I  designed  and  performed  two  series  of
experiments in which the effects of a previous dynamic exercise bout in hypoxia (Experiment 1)
and  the  simultaneous  exposure  to  hypoxia  (Experiment  2)  on  metaboreflex  activation  were
evaluated.
Considering the effects of hypoxia on SV and SVR illustrated so far, we hypothesized that it could
impair the ability of metaboreflex to increase SV and prevent SVR to increase as a compensatory
mechanism,  leading  to  a  blunted  BP  response.
In  my  opinion,  these  studies  could  provide  new  useful  insights  regarding  the  cardiovascular
adaptations  to  extreme  environments,  a  topic  that  is  receiving  growing  interest  in  aerospace
medicine. In fact, hypoxic exercise has been recently proposed as a valuable training method to
increase physical condition prior, during and after returning from spaceflight missions (Willis et al.
2019) This training protocol could help to reduce the effects of prolonged microgravity on human
body like  a  decreased  aerobic  fitness,  muscle  and  bone  atrophy  and  an  overall  cardiovascular
dysfunction (Demontis et al. 2017). Moreover, good acclimatization to the hypoxic environment
could help the astronauts to better face any loss of pressure that could lower the partial pressure of
oxygen  in  the  space  habitat  (Lewis   2018).   In  light  of  the  above,  a  better  understanding  of
cardiovascular adaptation to hypoxia is needed in the perspective of new space missions to explore
Mars and the recent development of space tourism, that could expose the challenging conditions of
space travel to people without adequate training.
MATERIALS AND METHODS
Population
Experiment 1
Seventeen healthy Caucasian subjects (including 7 females) aged 22–50 years agreed to participate
in  the  first  study.  All  were  well-trained  athletes  regularly  involved  in  endurance  competitions
(cycling, triathlon, and marathon running). The protocol was not completed by all the subjects as
seven of them complained of unbearable fatigue during the EH test. Thus, they were excluded from
results, which included the remaining ten subjects (four females and six males). Their age, body
mass, and height were 35.6 ± 8.4 years, 66.8 ± 12.6 kg, and 174.6 ± 9.3 cm, respectively. 
Experiment 2 
Eleven  healthy  Caucasian  male  subjects  aged  22–46  years  were  recruited  to  participate  in  the
second  study.  All  were  athletes  regularly  involved  in  leisure-time  sports  activities  at  least  3
times/week.  Their age, body mass, and height were 35.6 ± 8.4 years, 71.8 ± 10.3 kg, and 174.5 ± 5.
cm, respectively. 
The subjects involved in both experimental protocols were considered healthy on the basis of a
preliminary medical examination (see experimental design). None had any history of cardiac or
respiratory disease or were taking any medication at the time of the experiment.  
All the subjects were normotensive and nonsmokers and were unaware of the nature of the study.
Subjects were asked to refrain from alcoholic beverages and caffeine for at least 24 h before the
experimental sessions. The study was performed according to the Declaration of Helsinki and was
approved by the ethics  committee  of  the University  of  Cagliari.  Written  informed consent  was
obtained from all the participants included in the study.
Experimental design
Preliminary test (Experiment 1 and 2)
All the subjects involved in the two experiments underwent a general medical visit. Afterward, a
cardiopulmonary test  (CPX) with a  gas analyzer  (VO2000,  MedGraphics  St.  Paul,  MN, USA),
calibrated immediately before each CPX, was conducted on a mechanically braked cycle ergometer
(Monark 828E, Vansbro, Sweden). 
The test consisted in a linear increase of workload (30 W min−1), starting at 30 W, at a pedaling
frequency of 60 rpm, until exhaustion, which was taken as the point at which the subject was unable
to maintain a pedaling rate of at least 50 rpm. During the CPX, anaerobic threshold (AT), maximum
workload (Wmax), and maximum oxygen uptake (VO2max) were measured. Achievement of VO2 max
was considered as the attainment of at least two of the following criteria:  (1) a plateau in VO2
despite increasing workload (< 80 ml min−1); (2) respiratory exchange ratio (RER) above 1.10; and
(3) heart rate (HR) ± 10 beats min−1 of predicted maximum HR calculated as 220-age (Howley et
al. 1995). The anaerobic threshold was determined using the  V-slope method, which detects AT
using a computerized regression analysis of VO2  slopes vs. the carbon dioxide production (VCO2)
plot during exercise (Beaver et al. 1986). VO2max was calculated as the average VO2 during the final
30  s  of  the  incremental  test.  During  the  preliminary  test,  participants  familiarized  with  the
laboratory equipment and staff. This allowed habituation to the environment and the ergometer that
was otherwise identical to the exercise under hypoxia sessions.
Experiment 1 protocol
Exercise under hypoxia sessions
After the preliminary visit (interval 4–7 days), each subject completed, in separate days (interval 3–
5 days), three randomly assigned exercise sessions: (1) an exercise session in normoxia (EN); (2) an
exercise session in normobaric hypoxia with a FiO2 of 15.5% (EH15.5%), which simulated the
partial  pressure  of  oxygen  at  an  altitude  of  2500  m;  (3)  and  finally,  an  exercise  session  in
normobaric hypoxia with a FiO2 of 13.5% (EH13.5%), which simulated an altitude of 3500 m.
Exercise sessions were conducted on the same bicycle employed for the CPX test.  During each
session, the subject exercised for 10 min at 80% of the AT previously assessed during the CPX.
Throughout the sessions, the subject was connected with a facemask to a hypoxic gas generator
(Everest Summit II Generator, Hypoxico, New York, USA). This device utilizes a molecular sieve
system that  uses  zeolites  to  separate  nitrogen from O2 in  the  air,  and consequently provides  a
nitrogen-rich gas mixture, to purge the atmosphere within the container. Connected to the container,
and in conjunction with a one-way pressure relief  valve, the hypoxic generators can reduce the
concentration of O2 up to about 12.5%, which corresponds approximately to the O2 pressure at 4000
m altitude.  The level  of oxygen concentration  was adjusted by the operator  on the basis  of an
oxygen analyzer provided with the device (Maxtec, Handi+, Salt Lake City, UT, USA). The applied
generator setting was blinded to the athlete and controlled every minute by the operator. This device
is commonly used for training in normobaric hypoxia (Schega et al. 2016). Before commencing
sessions, the athlete was connected to the hypoxic generator and rested for 3 min to reach a stable
condition  in  respiratory  gas  exchange.  Throughout  sessions,  subjects  were  also  monitored  for
peripheral blood O2 saturation (SO2), measured by finger pulse oximetry. To further detect the real
presence of body hypoxemia, cerebral tissue oxygenation (COX) was assessed with near-infrared
spectroscopy (NIRS) (Nonin, SenSmart X-100, Plymouth, MN, USA). Briefly, one NIRS sensor
was placed on the left forehead above the eyebrow. The probe was covered and maintained with a
headband and taped to reduce the intrusion of extraneous light. Care was taken to ensure that the
attached probe did not constrict the head and did not block the circulation.
Test for metaboreflex function assessment 
A brief  recovery was allowed after  each exercise  session  (10 min).  Then (within  15 min),  the
participants were subjected to the following protocol,  randomly assigned to study the effects  of
hypoxic exercise on hemodynamic responses during the metaboreflex:
– Post-exercise muscle ischemia (PEMI):  This session was composed of 3 min of resting,
followed  by 3  min  of  exercise,  consisting  of  cycling  at  mild  intensity  (30% of  Wmax
measured during the CPX) at 60 rpm. The cycling period was followed by 3 min of PEMI
on the right leg. Ischemia was induced by rapidly (in less than 3 s) inflating, at the cessation
of exercise, a thigh cuff, to 50 mmHg above peak exercise systolic pressure. The cuff was
kept inflated for 3 min. A further 3 min of recovery was allowed after the cuff was deflated,
for a total of 6 min of recovery. Thus, the total PEMI session duration was 12 min. This
protocol, although conducted at mild intensity, has demonstrated the ability to "trap" muscle
metabolites in the exercising limb and to stimulate  the metaboreceptors (Crisafulli  et al.
2008; Scott et al. 2002). PEMI is effective in eliciting substantial hemodynamic responses in
terms of cardiac contractility, pre-load, and after-load (Crisafulli et al. 2008; Marongiu et al.
2013; Milia et al. 2015; Roberto et al. 2012; Scott et al. 2002). This response is suggested to
be  mediated  only  by  the  metaboreflex,  since  in  this  setting,  the  central  command  and
mechanoreflex activation are no longer present (Bastos et al. 2000; Crisafulli et al. 2011;
Nobrega et al. 2014); 
– Control exercise recovery (CER) session:  The same rest-exercise protocol used for PEMI
was used, but the recovery was conducted without cuff inflation. 
The  PEMI  and  the  CER  tests  were  randomized  and  recovery  was  allowed  between  sessions
(approximately 15 min). Recovery was considered complete when HR was not higher than 5 bpm
compared with the pre-exercise level. The study design is summarised by Fig. 1. All experiments
were carried out in a temperature-controlled, air-conditioned room (22 °C—relative humidity 50%).
To eliminate any potential effect of hormonal changes on hemodynamics, all women were tested in
the follicular phase of the menstrual cycle (i.e., within 10 days from the start of menstruation) as
self-reported. Please refer to Figure 1 for a visual explanation of the test.
Experiment 2 protocol
Test for metaboreflex function assessment with simultaneous hypoxia exposure 
After  a  few  days  (interval  4-7)  from the  preliminary  test,  the  subjects  involved  underwent  a
randomly assigned normoxic (NORMO) and hypoxic (HYPO) CER/PEMI sessions in two separate
days.  After  1  minute  of  rest,  the  subjects  were  connected  to  the  hypoxic  gas  generator  mask
previously described and performed CER and PEMI protocols wearing it throughout the tests both
in NORMO and HYPO sessions. During HYPO sessions, a gas mixture with a FiO2  of 13,5%,  was
delivered to the subjects, simulating an altitude of about 3500 mt. To assess whether the hypoxic
stimulus was effective, all subjects were monitored for SO2  and COX as happened in Experiment 1.
See Fig 2. and 3. for a visual explanation of the test. 
Hemodynamic assessment during metaboreflex activation (Experiment 1 and 2)
Throughout  all  sessions  of  metaboreflex  activation,  subjects'  hemodynamics  were  collected  by
impedance cardiography (NCCOM 3, BoMed Inc., Irvine, CA), which has been previously utilized
in  similar  experimental  settings  (Crisafulli  et  al.  2008,  2009,  2011).  This  device  allows  for
continuous, non-invasive, hemodynamic evaluation. The rationale of its use is based on the fact that
pulsatile aortic blood flow, due to ventricular systole, induces proportional fluctuation in electrical
conductivity. Therefore, changes in thoracic impedance (Z0) are representative of the blood volume
ejected during systole. By employing standard formulas, the SV can be estimated from Z0 variations
(Bernstein  1986).  The  data  acquisition  procedure  is  described  in  detail  in  previous  research
(Crisafulli  et  al.  2008, 2009, 2011). Briefly,  analog traces provided by impedance cardiography
along with ECG were collected and stored by means of a digital chart recorder (ADInstruments,
PowerLab 8sp, Castle Hill, Australia) at a sampling rate of 500 Hz. Z0 and its first derivative (dZ/dt)
were collected, stored, and analyzed afterward offline. Stored traces were also used to calculate
beat-to-beat HR, which was estimated as the reciprocal of the electrocardiogram R–R interval. The
pre-ejection period (PEP) and the left ventricular ejection time (VET) were also measured from
impedance traces. PEP corresponds to the time interval between the onset of QRS complex of ECG
and the beginning of  the systolic  deflexion of  dZ/dt,  while  VET was measured  as the interval
between the beginning of systolic dZ/dt deflection and the minimum of dZ/dt curve relative to the
same cardiac cycle. Diastolic time (DT) was measured by subtracting the sum of PEP and VET
from the cardiac cycle total period, measured as R-R interval. The ventricular filling rate (VFR),
which is a measure of the mean rate of diastolic blood flux, was obtained by dividing SV by DT
(Gledhill et al. 1994; Marongiu et al. 2013; Milia et al. 2015). The mean ventricular ejection rate
(VER),  an  index  of  myocardial  performance,  was  obtained  by  calculating  the  SV/VET  ratio
(Gledhill et al. 1994; Sanna et al. 2017). CO was obtained as the product of SV by HR. A standard
manual sphygmomanometer was employed for systolic (SBP) and diastolic (DBP) blood pressure
assessment, which was performed on the non-dominant arm by the same physician throughout all
protocol sessions. Mean arterial blood pressure (MAP) was calculated with the formula by Moran
(Moran et  al.  1995;  Sainas  et  al.  2016),  which takes  into  account  changes  in the diastolic  and
systolic time due to exercise-induced tachycardia in calculating MAP. To have a measure of global
vascular resistance, SVR was calculated by multiplying the MAP/CO ratio by 80, where 80 is a
conversion factor to change units to standard resistance units.
Data Analysis (Experiment 1 and 2)
Data are shown as mean ± SD. All collected data were averaged over 1 min. Differences in SO2 and
COX were assessed using a two-way analysis of variance (ANOVA) (factors of time and condition:
EN, EH15.5%, and EH13.5% for Experiment 1, NORMO and HYPO for Experiment 2) followed
by Bonferroni post hoc where appropriate.  Hemodynamic  values at  rest,  at  the third minute of
exercise,  and  at  the  third  minute  of  PEMI  (when  a  steady-state  in  metaboreflex  activity  was
expected  to  be  reached)  during  the  metaboreflex  tests  were  assessed.  Two-way  ANOVA  was
utilized to compare hemodynamic data for the effects of test (PEMI and CER) and condition (EN,
EH15.5%, and EH13.5% sessions for Experiment 1 and NORMO and HYPO for Experiment 2)
followed by Bonferroni post hoc when appropriate. 
To further assess the metaboreflex activity, the following procedure was employed: the difference
in the level of variables between the post-exercise ischemia phases of the PEMI and the CER test at
the third minute of recovery was calculated. This procedure enabled metaboreflex response to be
assessed, i.e., the response due to the metaboreflex activity (Crisafulli et al. 2013; Milia et al. 2015).
Unpaired  samples  T-Test  was  used  to  assess  any  differences  between  Experiment  1  and  2
populations CPX variables. Differences in measured variables due to metaboreflex response were
assessed by means of the one-way repeated measures ANOVA test, followed by Bonferroni post
hoc when appropriate for Experiment 1 and Paired samples T-Test for Experiment 2. Statistical
analysis was performed by utilizing commercially available software (GraphPad Prism). Statistical
significance was established as a p-value of < 0.05 in all the cases. 
RESULTS
Experiment 1
The results of the CPX test are shown in Table 1. During exercise  sessions, subjects cycled at a
workload corresponding to 187.2 ± 3.4 W, i.e., 80% of AT. The time course of SO2  and COX is
illustrated  in  Fig.  4.  There  was  a  progressive  reduction  in  SO2 throughout  the  EH15.5% and
EH13.5% sessions with respect to EN (panel A). Even though the EH13.5% appeared to induce a
stronger SO2 reduction than the EH15.5% test, no statistical difference was demonstrated between
sessions, with the exception of the second minute of exercise. Panel B of Fig. 3 shows that COX
(reported  as  % changes  from rest)  progressively decreased during the EH15.5% and EH13.5%
sessions as compared to EN, without any significant difference between the two exercise sessions
conducted in hypoxia. 
Table 2 shows the mean values of hemodynamic parameters gathered during rest periods preceding
the PEMI and the CER tests. The SV was the only parameter affected by condition, as it was on
average reduced by the EH15.5% and the EH13.5% sessions, as compared to EN. 
Table 3 shows that at the third minute of exercise, preceding the PEMI and the CER maneuvers,
none of the hemodynamic parameters were influenced by test or condition. 
Figures 5 and 6 depict hemodynamic variables obtained during the third minute of recovery of the
PEMI and the CER tests. Panel A of Fig. 5 demonstrates that HR was on average higher after the
EH15.5% and EH13.5% sessions,  with  respect  to  EN (p= 0.042 for  condition).  No significant
difference was found for HR response between conditions (panel B). The SV was significantly
reduced by exercise in hypoxia (p = 0.042 for condition, panel C). Moreover, exercise in hypoxia
significantly  reduced  SV response  (panel  D)  with  respect  to  EN.  The  CO was  unchanged  by
exercise in hypoxia, neither in absolute values (panel E), nor in terms of its response (panel F).
Figure  6a  illustrates  that  the  absolute  values  of  VFR were  unaffected  by exercise  in  hypoxia.
However, its response was significantly lower after EH15.5% and EH13.5% as compared to EN
(panel  B).  Similarly,  VER was not  significantly  different  among  treatment  with  hypoxic  gases
(panel C), but its response was reduced in EH15.5% and EH13.5% sessions in comparison with EN
(panel D). The MAP was significantly influenced by test, as this parameter was higher during the
PEMI than during the CER maneuvers (p = 0.0005 for test effect, panel E) without any detectable
difference in its response (panel F). Finally, panel G of Fig. 6 demonstrates that the PEMI tests
induced higher SVR than the CER tests (p = 0.039 for test effect). Furthermore, the response in this
parameter was more elevated after both sessions of exercise in hypoxia than in normoxia (panel H).
Experiment 2
Results of the CPX are reported in Table 4. During Experiment 2 subjects showed a lower VO2 max
than Experiment 1 individuals  (p=0.008). Figure 7 illustrates the behavior of SO2 (panel A) and
COX (panel B) during NORMO CER, NORMO PEMI, HYPO CER, and HYPO PEMI. There was
a statistically significant reduction in both variables during the hypoxic sessions that started at third
minute of rest in HYPO PEMI and fourth minute of rest in HYPO CER, continuing for the entire
duration of the protocols. 
Table 5 shows the mean values of hemodynamic parameters gathered during the fourth minute of
rest preceding the PEMI and the CER tests. No differences were detected between NORMO and
HYPO sessions. Table 6 shows that at the third minute of exercise preceding the PEMI and the CER
maneuvers, none of the hemodynamic parameters were influenced by test or condition as happened
in  Experiment  1.  Figures  8  and  9  illustrate  hemodynamic  variables  measured  during  the  third
minute of recovery of the PEMI and the CER tests. 
Panel A of Fig. 8 shows that HR was unaffected by hypoxia and no significant difference was found
for HR response between conditions either (panel B).  SV was not significantly affected by exercise
in hypoxia, but SV response showed a significant reduction in HYPO (panel D,  p= 0.0205) with
respect to NORMO. The CO was affected by test (p= 0.013) with a significant increase in PEMI
only during NORMO tests (panel E), with CO response being increased during NORMO tests with
respect to HYPO tests (panel F, p=0.021). 
Panel A of figure 9 illustrates that the absolute values of VFR were unchanged during NORMO and
HYPO  tests.  However,  its  response  was  significantly  lower  during  HYPO  sessions  (panel  B,
p=0.0034). Regarding VER, there was not significant difference among treatments with hypoxic
gas (panel C), and its response seemed not to be affected by condition (panel D). MAP was not
significantly  influenced  by test  (panel  E),  with  no  significant  differences  in  response  analysis.
Finally, panel G and H of Fig. 9 demonstrates that there were no differences in SVR values between
NORMO and HYPO (panel G), but there was an almost significant (p=0.070) difference in SVR
response, with SVR being higher during PEMI in hypoxia (panel H). 
DISCUSSION
The main aim of the present study was to discover whether hypoxia could alter the cardiovascular
response  during  the  metaboreflex  activation  in  two  different  experimental  set-ups:  a  previous
exercise  session  in  hypoxia  and  simultaneous  hypoxia  exposure.  Our  hypothesis  was  that  the
capacity to globally vasoconstrict both the arteriolar and the venous beds was impaired due to the
production of vasodilating metabolites able to restrain the metaboreflex-induced vasoconstriction
(Casey and Joyner  2012). It  has, in fact,  been demonstrated that  during the metaboreflex,  both
arteriolar and venous circulation is constricted by the augmented sympathetic tone (Crisafulli et al.
2017; Marongiu et al. 2013; Nobrega et al. 2014; Sheriff et al. 1998; Shoemaker et al. 2005). 
Although no direct measure of venous constriction was gathered, results show that hypoxia led to an
impairment  in  the capacity  to enhance  venous return,  as  testified  by the reduction  in  the VFR
response. This parameter has already been utilized in recent research on the metaboreflex and has
been able to detect  reductions in venous return and diastolic  functions during the metaboreflex
(Crisafulli et al. 2009; Magnani et al. 2018; Marongiu et al. 2013; Mulliri et al. 2016; Roberto et al.
2017). The lack of any VFR response indicates that the capacity to centralize blood volume was
negatively affected by hypoxia and that  this  occurrence led to a reduction  in the SV response.
Indeed, SV response was lower after EH and during HYPO sessions, with SV absolute values also
being affected after EH. 
Several researchers have demonstrated that the capacity to increase cardiac pre-load is pivotal to
achieving normal hemodynamics during the metaboreflex (Bastos et al. 2000; Crisafulli et al. 2009;
Marongiu et al. 2013; Milia et al. 2015). Studies have reported that the capacity to centralize blood
volumes,  by  means  of  visceral  and  venous  constriction,  supports  ventricular  performance,  by
recruiting  the  Frank–Starling  mechanism.  This  allows  SV  to  increase during  the  metaboreflex
(Bastos et al. 2000; Crisafulli et al.  2009; Marongiu et al. 2013; Milia et al. 2015; Sheriff et al.
1998; Shoemaker et al. 2005). It is to be noted that the impaired SV was not compensated by any
HR response. Although HR was on average higher during both the PEMI and the CER test after EH
sessions, the response in this variable (i.e., the difference between the PEMI and the CER test) was
unaffected  by condition  in  both EH and HYPO sessions.  This  is  in  good accordance  with  the
concept  that  HR  does  not  usually  participate  in  the  hemodynamic  adjustments  during  the
metaboreflex obtained by PEMI (Crisafulli et al. 2011, 2015; Fisher et al. 2013; Iellamo et al. 1999;
Nishiyasu et al. 1994). 
This finding supports the concept that during PEMI, reductions in cardiac pre-load are compensated
mainly by arteriolar  constriction,  rather  than by chronotropic increments  (Crisafulli  et  al.  2011;
Mulliri et al. 2016; Roberto et al. 2017). Another consequence of the impaired VFR response was
the  reduced  capacity  to  increase  VER  during  the  metaboreflex  after  EH.  This  parameter  is
considered to be directly related to myocardial performance and it is sensible to make modifications
in both cardiac inotropism and pre-load (Gledhill  et al.  1994; Sanna et  al.  2017). Indeed, VER
response was on average positive after EN and negative after both sessions of EH. 
It is worth mentioning that during Experiment 2, no differences were detected in HR and VER
response  during  NORMO  and  HYPO  sessions.  These  results  seems  to  be  in  contrast  with
Experiment  1  outcomes.  This  different  finding is  likely related  to  the  intensity  of  the  hypoxic
stimulus and the level of athletic fitness of the population involved in Experiment 1 and 2. In fact,
the hypoxic exercise sessions in Experiment 1 were longer in duration (10 minutes vs 3 minutes)
and  could  have  elicited  a  stronger  chemoreflex  activation  and  hypoxia-related  metabolites
production even if it preceded the metaboreflex activation by several minutes. Moreover, it was
recently demonstrated that exercise in hypoxic conditions at a fixed load induces a stronger level of
hypoxemia in athletes with a greater aerobic fitness than in less trained subjects (Van Thienen et al.
2016). This fact probably led the well-trained Experiment 1 population to undergo a greater hypoxic
stimulus with respect to less-trained Experiment 2 subjects. 
As far as SVR is concerned, this parameter was increased after the hypoxic test when compared to
normoxic ones in both experiments, with SVR response being close to significance in Experiment 2.
This indicates that the capacity to vasoconstrict the arteriolar bed was not impaired by hypoxia.
Rather,  it  was enhanced,  and this  occurrence  speaks  against our initial  hypothesis  that hypoxia
could reduce gross vascular resistance due to vasodilating metabolite accumulation. 
A possible explanation for the increased SVR response found after hypoxic stimulation may be that
the baroreflex activity was effective in counteracting the reduced CO response by recruiting the
after-load reserve and inducing arteriolar constriction. This phenomenon explains the unchanged
MAP found during the metaboreflex  after  and during  hypoxia  exposure.  Hence,  the baroreflex
successfully maintained the MAP response, despite the reduced SV and CO response. 
It  remains  to  be  explained  why hypoxia  affected  the  venous  bed  without  modifying  arteriolar
vasoconstriction. It was likely due to hypoxia producing a variety of vasodilating metabolites, such
as NO, adenosine, and prostaglandin-derived factors (Dinenno 2016; Marshall 2015). In this regard,
it is to be noted that oral nitrates were found to exert a venodilator effect with a quantitatively lesser
effect on arteriolar resistance vessels. In particular, it has been demonstrated that exercise sessions
in the administration of NO-donors before the metaboreflex activation impairs cardiac pre-load by
inducing venous dilation, whereas effects on SVR were less evident (Koole et al. 2000; Marongiu et
al. 2013). Moreover, recent research showed that preconditioning maneuvers, able to augment the
NO-production, resulted in an impaired possibility to induce venous constriction and to increase SV
during the metaboreflex in healthy subjects (Mulliri et al. 2016). It is then possible, in the current
study, that the hypoxia increased the production of NO (likely the main vasodilatory contributor)
and—to  a  lesser  extent—other  metabolites  (prostaglandins?)  which  in  turn  restrained  the
sympathetic- induced venous constriction during the metaboreflex (Casey and Joyner 2012). This
occurrence prevented the recruitment of the Frank-Starling mechanism and reduced SV response,
although it must be acknowledged that this hypothesis remains speculative since the present study
did not measure metabolite production.  
Another  possible  explanation  for  the SV reduction  found in our study is  the hypoxia-mediated
arteriolar vasoconstriction of the pulmonary vascular bed. Indeed, it is has been demonstrated that
hypoxia exposure leads to an increase in pulmonary arteries vasoconstriction (Michiels 2004) that
has been recently shown to produce an increased pulmonary artery systolic pressure (Stembridge et
al. 2014; Stembridge et al. 2015b). It can be hypothesized that the augmented pulmonary vascular
resistance reduced the volume of blood ejected by the RV into the pulmonary vascular bed, leading
to a reduced LV filling and a consequent  reduction of LV preload.  This in turn resulted in an
impaired SV. Echocardiographic studies are required to elucidate this possible explanation of SV
reduction after and during acute exposure to hypoxia. 
To summarize, our study proposed that hypoxia-induced metabolite production which restrained the
sympathetic-induced venous constriction induced by the metaboreflex activation. This effect could
have been further amplified by pulmonary vasoconstriction, leading to a reduced volume of blood
filling the LV. This resulted in an impaired capacity to recruit the pre-load reserve and, in turn,
prevented the possibility to increase SV during the metaboreflex.
It is to be highlighted that baroreflex activation successfully defended MAP by increasing gross
vascular resistance notwithstanding the reduced SV. That is, there was a functional shift from a
flow- to a vasoconstriction-mediated mechanism for maintaining the target blood pressure during
the metaboreflex. 
To the best of our knowledge, the present study is the first to report on the hemodynamics during
the  metaboreflex  elicited  immediately  after  a  single  bout  of  hypoxic  exercise.  In  the  past,
metaboreflex was studied during hypoxia,  but without the assessment  of central  hemodynamics
(Gujic et al. 2007; Houssiere et al. 2005). Instead, only blood pressure and HR were collected along
with SNA. Thus, there are no studies to compare the present results with. The paucity of research
dealing  with  the  hemodynamic  consequences  of  intermittent  hypoxia  is  somewhat  surprising
considering that the use of normobaric hypoxic devices has become popular in athletes and patients
(Millet et al. 2016). However, the pros and cons of these practices have yet to be demonstrated. In
particular,  the  transition  from  hypoxia  to  normoxia  may  be  critical  since  the  cardiovascular
homeostasis is challenged. It should also be considered that mild hypoxia may be protective from
ischemic events by inducing the phenomenon known as ischemic preconditioning and by promoting
neurogenesis  (Marongiu  and Crisafulli  2014;  Tsai  et  al.  2013).  Hence,  the  weight  of  scientific
evidence about the effects of hypoxia on the cardiovascular apparatus remains equivocal since both
detrimental and positive effects have been reported. Further study on the cardiovascular effects of
hypoxia is then warranted.
Limitations of the study
One potential limitation of the present investigation was that we did not measure the production of
any metabolite during the two hypoxic tests. This kind of assessment would have been useful as
hypoxia is known to induce the production of a variety of vasodilating metabolites, such as NO,
adenosine, and prostaglandin-derived factors (Dinenno 2016). Unfortunately, these measurements
are complex, expensive, and somewhat invasive. However, results of SO2 and COX confirm that a
substantial hypoxia was induced by hypoxic tests in with respect to normoxic ones. Inasmuch as
hypoxia is known to increase metabolites production (Casey and Joyner 2012), it was then likely
that  hypoxic  bouts  induced  greater  metabolic  by-products  accumulation  than  normoxic  ones.
Moreover, we could not measure VO2 during hypoxic bouts since the gas analyzer was not set up to
be used simultaneously with the hypoxic gas generator because of technical reasons. 
Another  limit  was  that  the  rise  in  MAP  found  during  PEMI  could  potentially  be  due  to  the
mechanical effect of the circulatory occlusion and not to metaboreflex activation. However, in our
opinion, it is very unlikely that mechanical circulatory occlusion in one leg  per se would cause
substantial hemodynamic changes. Early as well as more recent findings reported that mechanical
occlusion alone in one or two legs/arms could not induce any detectable hemodynamic effect. For
example, already in 1976, Rowell and co-workers (Rowell et al. 1976) reported that total circulatory
occlusion of both resting legs for 15 min had little  or no effect  on HR or MAP. They further
concluded that  a  work factor  (i.e.,  metabolites  production)  seems  necessary for  any significant
cardiovascular response to be generated by muscle ischemia. Therefore, mechanical stimulation of
muscle is not a major factor in generating pressor responses. Moreover, in the recent past some
experiments  conducted  in  our  lab  did  not  discover  any  hemodynamic  effect  due  to  regional
circulatory occlusion (in one leg) not preceded by exercise (Crisafulli et al. 2008). Thus, results
from these studies do not support the thesis that circulatory occlusion per se can cause significant
hemodynamic changes. 
A final potential limitation of the present investigation was that the study population was limited to
young,  healthy,  Caucasian  trained  subjects  and results  can not  be  extended either  to  a  general
population.  In  conclusion,  data  from  the  present  research  demonstrated  that  exercise  in  acute
hypoxia  impairs  the  capacity  to  enhance  venous  return  during  the  metaboreflex  elicited  in
normoxia,  immediately  after  EH  sessions.  The  reduced  capacity  to  increase  venous  return
negatively  affects  SV,  which  can  not  participate  in  the  hemodynamic  response  during  the
metaboreflex.  This in turn causes a functional shift from a flow- to a vasoconstriction-mediated
mechanism by which the target blood pressure is achieved during the metaboreflex. Importantly, the
described dysregulation was successfully counteracted by cardiovascular controlling mechanisms
(probably the baroreflex), which maintained MAP notwithstanding the reduced SV. 
CONCLUSIONS AND FUTURE DIRECTIONS
The results of my research illustrated the effects of exposure of both previous and concomitant
hypoxia on the hemodynamic responses induced by metaboreflex activation. The hypoxia-mediated
impairment of SV response to metaboreflex may explain, at least  in part,  the impaired exercise
capacity that human beings experience when they are exposed to enviroments with reduced O2
content.
Considering that hypoxia is a challenge commonly faced in the aerospace environment, my research
could  give  new  useful  hemodynamc  information  for  aviation  and  space  medicine.
Further studies are required to better elucidate the mechanisms behind the hemdoynamic scenario
depicted by my experiments.  In particular,  Echocardography could give direct measurements of
venous  return  and  arterial  pulmonary  pressure  to  confirm  our  hypothesis  on  what  causes  SV
reduction. 
TABLES AND FIGURES
AT Wmax
Workload (W) 234 ± 38 297 ± 58
VO2 (ml kg -1 min -1) 40.1 ± 10.9 45.8 ± 11.9
VO2 (ml min -1) 2537 ± 556 2903 ± 626
VCO2 (ml kg -1 min -1) 2817 ± 650 3697 ± 960
RQ 1.11 ± 0.09 1.27 ± 0.14
Ve (l min -1) 68.8 ± 15.5 98.1 ± 27.9
HR (bpm) 155 ± 7 168 ± 6
Table 1. Metabolic data values at the anaerobic threshold (AT) and at maximum workload (Wmax) 
collected during cardiopulmonary test of the subjects involved in Experiment 1.
EN EH 15,5% EH 13,5% p value 
condition 
effect
p value test 
effect
HR (bpm) PEMI 77 ±11
CER 81 ± 10
PEMI 84 ± 9
CER 79 ± 8
PEMI 88 ± 9
CER 83 ± 9
0.102 0.338
SV (ml) PEMI 62.2 ± 
12.7
CER 64.5 ± 
8.7
PEMI 53.1 ± 
10.7
CER 54.8 ± 
12.6
PEMI 52.9 ± 
9.7
CER 59.0 ± 
15.6
0.048 0.327
CO (l min-1) PEMI 4.76 ± 
0.9
CER 5.25 ± 
1.00
PEMI 4.35 ± 
1.13
CER 4.59 ± 
1.19
PEMI 4.74 ± 
1.15
CER 4.86 ± 
1.19
0.306 0.322
VFR (ml s-1) PEMI 161.0 ± 
38.7
CER 194.0 ± 
56.5
PEMI 174.2 ± 
57.5
CER 152.1 ± 
52.4
PEMI 177.2 ± 
54.4
CER 174.4 ± 
49.6
0.636 0.841
VER (ml s-1) PEMI 259.8 ± 
59.4
CER 268.9 ± 
45.6
PEMI 240.0 ± 
45.0
CER 241.8 ± 
60.3
PEMI 242.9 ± 
52.7
CER 255.7 ± 
59.1
0.387 0.573
MAP (mmHg) PEMI 81.6 ± 
9.1
CER 83.1 ± 
8.4
PEMI 81.9 ± 
7.8
CER 84.6 ± 
8.5
PEMI 85.6 ± 
7.6
CER 83.5 ± 
6.8
0.683 0.735
SVR (dynes s 
cm-5)
PEMI 1429.3 ±
379.3
CER 1310.8 ± 
282.9
PEMI 1480.9 ±
289.7
CER 1649.6 ± 
440.3
PEMI 1530.6 ±
424.2
CER 1474.9 ± 
471.4
0.275 0.985
Table 2.  Hemodynamic  values  during rest  periods  preceding the postexercise  muscle  ischemia
(PEMI)  and the  control  exercise  recovery  (CER)  tests  in  the  three  conditions:  EN  exercise  in
normoxia;  EH15.5% exercise in hypoxia with FiO2 = 15.5%; and  EH13.5% exercise in hypoxia
with FiO2 = 13.5%.
EN EH 15,5% EH 13,5% p value 
condition 
effect
p value test 
effect
HR (bpm) PEMI 117 ± 14
CER 119 ± 13
PEMI 117 ± 10
CER 116 ± 10
PEMI 117 ± 10
CER 119 ± 12
0.823 0.831
SV (ml) PEMI 99.7 ± 
32.9
CER 124.4 ± 
42.8
PEMI 115.6 ± 
35.7
CER 125.3 ± 
37.4
PEMI 105.1 ± 
27.3
CER 109.7 ± 
28.7
0.455 0.134
CO (l min-1) PEMI 11.83 ± 
4.3
CER 14.75 ± 
4.9
PEMI 13.64 ± 
5.06
CER 14.67 ± 
5.08
PEMI 12.52 ± 
4.30
CER 13.27 ± 
4.63
0.694 0.206
VFR (ml s-1) PEMI 488.4 ± 
195.8
CER 640.4 ± 
204.9
PEMI 556.4 ± 
221.6
CER 621.0 ± 
240.8
PEMI 531.7 ± 
239.7
CER 572.9 ± 
221.1
0.869 0.138
VER (ml s-1) PEMI 510.1 ± 
180.4
CER 585.8 ± 
199
PEMI 572.2 ± 
191.7
CER 586.7 ± 
169.9
PEMI 513.5 ± 
135.8
CER 544.8 ± 
149.6
0.650 0.367
MAP (mmHg) PEMI 97.9 ± 
11.7
CER 97.9 ± 
9.2
PEMI 96.3 ± 
6.3
CER 94.6 ± 
5.4
PEMI 95.9 ± 
8.6
CER 93.1 ± 
7.6
0.522 0.193
SVR (dynes s 
cm-5)
PEMI 768.5 ± 
432.3
CER 609.3 ± 
272.0
PEMI 623.3 ± 
193.9
CER 578.6 ± 
210.5
PEMI 664.4 ± 
176.5
CER 620.6 ± 
221.4
0.424 0.492
Table 3. Hemodynamic values at the third minute of exercise of the post-exercise muscle ischemia 
(PEMI) and the control exercise recovery (CER) tests in the three conditions: EN exercise in 
normoxia; EH15.5% exercise in hypoxia with FiO2 = 15.5%; and EH13.5% exercise in hypoxia 
with FiO2 = 13.5%.
AT Wmax
Workload (W) 140.90 ± 31.68 252,27 ± 41,25
VO2 (ml kg -1 min -1) 21.7.1 ± 3.26 34.69 ± 3.70
VO2 (ml min -1) 1569 ± 420 2527 ± 466
VCO2 (ml kg -1 min -1) 1771 ± 440 3533 ± 616
RQ 1.10 ± 0.1 1.40 ± 0.08
Ve (l min -1) 38.82 ± 10.9 94.02 ± 21.75
HR (bpm) 140 ± 12 174 ± 9
Table 4. Metabolic data values at the anaerobic threshold (AT) and at maximum workload (Wmax) 
collected during cardiopulmonary test of the subjects involved in Experiment 2.
NORMO HYPO p value condition 
effect
p value test 
effect
HR (bpm) PEMI 94.41 ± 
12.76
CER 92.90 ± 11.63
PEMI 88.67 ± 8.80
CER 88.65 ± 11.63
0.828 0.163
SV (ml) PEMI 60.45 ± 
12.39
CER 63.77 ± 13.99
PEMI 60.45 ± 9.69
CER 69.10 ± 17.26
0.520 0.152
CO (l min-1) PEMI 5.64 ± 1.23
CER 5.85 ± 1.28
PEMI 5.35 ± 0.97
CER 6.14 ± 1.89
0.998 0.240
VFR (ml s-1) PEMI 230.52 ± 
56.03
CER 246.47 ± 
102.4
PEMI 195. 47 ± 
59.44
CER 240.88 ± 
116.96
0.444 0.251
VER (ml s-1) PEMI 263.04 ± 
54.62
CER 271.77 ± 
46.29
PEMI 261.09  ± 
50.30
CER 286.30 ± 
71.46
0.714 0.325
MAP (mmHg) PEMI 84.69 ± 
11.37
CER 88.03 ± 7.55
PEMI 82,72 ± 
11.03
CER 85.45 ± 11.37
0.475 0.342
SVR (dynes s 
cm-5)
PEMI 1249.06 ± 
259.15
CER 1249.09 ± 
311.23
PEMI 1285.95 ± 
348.74
CER 1178.54 ± 
265.89
0.853 0.554
Table 5.  Hemodynamic values during the fourth minute of rest of postexercise muscle ischemia
(PEMI) and the control exercise recovery (CER) tests in the two conditions: normoxia (NORMO)
NORMO HYPO p value condition 
effect
p value test 
effect
HR (bpm) PEMI 146.19 ± 
11.42
CER 139.58 ± 
16.89
PEMI 146.08 ± 
13.59
CER 144.91 ± 
14.60
0.548 0.371
SV (ml) PEMI 143.14 ± 
44.95
CER 135.49 ± 
54.02
PEMI 129.42 ± 
47.70
CER 154.15 ± 
48.97
0,868 0,567
CO (l min-1) PEMI 21.21 ± 5.87
CER 18.91 ± 7.71
PEMI 18.96 ± 7.51
CER 22.72 ± 6.77
0.713 0.732
VFR (ml s-1) PEMI 1180.72 ± 
546.28
CER 978.12 ± 
482.98
PEMI 850.27 ± 
350.95
CER 1071.12 ± 
464.89
0.404 0.949
VER (ml s-1) PEMI 796.75 ± 
239.71
CER 760.29 ± 
215.00
PEMI 774.56 ± 
313.81
CER 792.75 ± 
274.21
0.949 0.909
MAP (mmHg) PEMI 102.12 ± 
11.86
CER 100.30 ± 
13.94
PEMI 101.21 ± 
9.69
CER 103.18 ± 
11.26
0.783 0.983
SVR (dynes s 
cm-5)
PEMI 486.16 ± 
221.48
CER 412.22 ± 
123.96
PEMI 473.36 ± 
140.85
CER 389.72 ± 
116.33
0.949 0.909
Table 6.  Hemodynamic  values at  the third minute of exercise of postexercise muscle ischemia
(PEMI) and the control exercise recovery (CER) tests in the two conditions: normoxia (NORMO)
exercise in hypoxia with FiO2 = 13.5% (HYPO).
Fig.  1.  Experiment  1  study  design.  After  the  cardiopulmonary  test  (CPX,  interval  4–7  days),
subjects underwent in separate days (interval 3–5 days), three randomly assigned exercise sessions,
each lasting 10 min at a workload corresponding to 80% of the AT previously measured during the
CPX. (1) Exercise session in normoxia (EN); (2) exercise session in normobaric hypoxia with a
FiO2 of 15.5% (EH15.5%); (3) and finally, an exercise session in normobaric hypoxia with a FiO2 of
13.5% (EH13.5%). After each exercise session, participants underwent randomly assigned the post-
exercise  muscle  ischemia  (PEMI)  and  the  control  exercise  recovery  (CER)  test  to  study  the
metaboreflex.
Fig. 2. Experiment 2 study design. After the CPX (4-7 days interval), the subjects underwent 2
randomly assigned metaboreflex activation protocols (PEMI/CER) in separate days (interval 3-5
days) in normoxia (NORMO) and normobaric hypoxia (HYPO). The hypoxic stimulus was induced
by letting the subjects breathe a gas mixture with 13.5 % of FiO2.
Fig  3.  Experimental  setup.  A.  The  figure  shows  a  subject  instrumented  with  Impedance
Cardiography,  NIRS  (near-infrared  spectroscopy)  and  the  mask  of  the  hypoxic  gas  generator
Hypoxico. B. Hypoxico main unit.
Fig.  4. A.  Changes  in  the  level  of  peripheral  blood O2  saturation  (SO2)  during  the sessions  of
exercise  in  normoxia  (EN),  in  normobaric  hypoxia  with  a  FiO2 of  15.5% (EH15.5%),  and  in
normobaric hypoxia with FiO2 of 13.5% (EH13.5%).  B Shows changes in cerebral oxygenation
(COX) during the same tests. Values are mean ± SD.  N  = 10. *p  < 0.05 vs. EN; †p  < 0.05 vs.
EH15.5%
Fig. 5 Absolute values and responses of cardiovascular parameters during the postexercise muscle
ischemia  (PEMI)  and  the  control  exercise  recovery  (CER)  test,  conducted  after  exercise  in
normoxia  (EN),  in  normobaric  hypoxia  with  a  FiO2 of  15.5% (EH15.5%),  and in  normobaric
hypoxia with FiO2 of 13.5% (EH13.5%). HR Heart rate (A,B),  SV stroke volume (C,D), and CO
cardiac output (E,F). Responses were calculated as the difference between the PEMI and the CER
test at the third minute of recovery. Values are mean ± SD. N = 10. Horizontal brackets indicate the
significant (p < 0.05) overall main effect of condition. There were no interaction effects. *p < 0.05
vs. EN
Fig. 6. Absolute values and responses of cardiovascular parameters during the postexercise muscle
ischemia (PEMI) and the control exercise recovery (CER) test conducted after exercise in normoxia
(EN), in normobaric hypoxia with a FiO2 of 15.5% (EH15.5%), and in normobaric hypoxia with
FiO2 of 13.5% (EH13.5%). VFR Ventricular filling rate (A,B), VER ventricular ejection rate (C,D),
MAP mean arterial pressure (E,F), and  SVR systemic vascular resistance (G,H). Responses were
calculated as the difference between the PEMI and the CER test at the third minute of recovery (see
text for further details). Values are mean ± SD. N = 10. Vertical brackets indicate the significant (p<
0.05) overall main effect of test. There were no interaction effects. *p < 0.05 vs. EN.
Fig. 7 A.  Changes in the level of peripheral blood O2  saturation (SO2)  during the PEMI and CER
sessions in normoxia (NORMO), and hypoxia (HYPO) with a FiO2 of 13.5% ). B Shows changes in
cerebral oxygenation (COX) during the same tests. Values are mean ± SD. N = 11. * p < 0.05 vs.
HYPO CER vs. NORMO CER. +  p < 0.05 vs. HYPO PEMI vs NORMO CER.
Fig. 8.  Absolute values and responses of cardiovascular parameters during the postexercise muscle
ischemia (PEMI) and the control exercise recovery (CER) test, conducted in normoxia (NORMO),
and in normobaric hypoxia with FiO2 of 13.5% (HYPO). HR Heart rate (A,B),  SV stroke volume
(C,D), and CO cardiac output (E,F). Responses were calculated as the difference between the PEMI
and the CER test at the third minute of recovery. Values are mean ± SD. N = 11. Vertical brackets
indicate the significant (p < 0.05) overall main effect of test. There were no interaction effects. *p <
0.05 NORMO PEMI vs.  NORMO CER for  the  absolute  values  analysis,  vs  NORMO for  the
response analysis.
Fig. 9. Absolute values and responses of cardiovascular parameters during the postexercise muscle
ischemia (PEMI) and the control exercise recovery (CER) test conducted in normoxia (NORMO),
and in normobaric hypoxia with FiO2 of 13.5% (HYPO). VFR Ventricular filling rate (A,B), VER
ventricular  ejection  rate  (C,D),  MAP  mean  arterial  pressure  (E,F),  and  SVR  systemic  vascular
resistance (G,H). Responses were calculated as the difference between the PEMI and the CER test
at the third minute of recovery (see text for further details). Values are mean ± SD. N = 11. Vertical
brackets indicate the significant (p  < 0.05) overall main effect of test. There were no interaction
effects. **p < 0.01 vs. NORMO.
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